Skip to main content
. 2023 Jun;29(6):1223–1227. doi: 10.3201/eid2906.221755

Table. Overview of longitudinal samples used in study of SARS-CoV-2 seroprevalence and immunity in cats, United Kingdom, April 2020–February 2022*.

Sample Days between sampling Titer
% Decrease per day
B.1 Alpha Delta B.1 Alpha Delta
Cat F 12 490 257 601 5.90 0.90 4.10


146
229
303




Cat G 175 586 677 243 0.40 0.40 0.40


134
170
58




Cat H 94 687 825 2,165 0.30 0.20 0.70


474
678
685




Cat J 175 627 719 247 0.30 0.40 0.40


318
241
79




Cat L 23 109 102 468 −7.20 1.40 1.60
289 70 301

*We used 2 samples from each of 5 animals, taken >12 d apart. The earlier sample was used in the overall analysis; however, newer samples were also tested. Values related to each variant are shown for each sample, with the earlier sample above and later below. Titers are color-coded by size (stronger titers and greater decreases are shown with darker shading). B.1 indicates ancestral/wild-type virus.